Potent antifungal activity was detected in fermentation extracts of Sporormiella australis and two related components were isolated from solid fermentations using silica gel and high speed countercurrent chromatography. The most active antifungal component, australifungin, contained a unique combination of a-diketone and jS-ketoaldehyde functional groups. Australifungin exhibited broad spectrum antifungal activity against humanpathogenic fungi with MICs against Candida spp., Cryptococcus neoformans, and Aspergillus spp. between 0.01 5 and 1.0 //g/ml. Modeof action studies revealed that australifungin interfered with fungal lipid metabolism by specifically inhibiting sphingolipid synthesis at the step converting sphinganine to ceramide.
(Received for publication December 12, 1994) Potent antifungal activity was detected in fermentation extracts of Sporormiella australis and two related components were isolated from solid fermentations using silica gel and high speed countercurrent chromatography. The most active antifungal component, australifungin, contained a unique combination of a-diketone and jS-ketoaldehyde functional groups. Australifungin exhibited broad spectrum antifungal activity against humanpathogenic fungi with MICs against Candida spp., Cryptococcus neoformans, and Aspergillus spp. between 0.01 5 and 1.0 //g/ml. Modeof action studies revealed that australifungin interfered with fungal lipid metabolism by specifically inhibiting sphingolipid synthesis at the step converting sphinganine to ceramide.
The increasing incidence of life-threatening fungal infections coupled with emerging resistance to fluconazole and the toxicity of amphotericin B emphasizes the need for new fungicidal drugs with different modes of inhibition. Our natural products screening program has focused on fermentation products of a wide phylogenetic array of filamentous fungi as sources of antifungal agents with therapeutic potential. One of most easily accessible groups of chemically uninvestigated fungi are the coprophilous fungi that inhabit dung of herbivorous mammals. A high proportion of coprophilous fungi thus far investigated have yielded a surprisingly diverse array of novel and moderately potent antifungal compounds1>2). Below we report on the discovery of australifungin
(1), a highly potent antifungal compound from a coprophilous fungus identified as Sporormiella australis. Australifungin inhibits sphingolipid synthesis at the sphinganine iV-acyltransferase, a mechanismthat is common to the mycotoxin, fumonisin Bl3). The producing organism, fermentation, isolation and biological activity of australifungin are described; details of the structure elucidation are provided elsewhere4). (1), australifunginol (2) , stemphyloxin (3), betaenone C (4), betaenone B (5) , and diplodiatoxin (6) .
Fermentation

Materials and Methods
THE JOURNAL OF ANTIBIOTICS
Vegetative mycelia of S. australis (MF5672 =ATCC 74157) were prepared by inoculating mycelium, that had been frozen and stored in 10%glycerol (-80°C), into a 250-ml unbaffled Erlenmeyer flask containing 54ml of the seed medium described previously5). Seed cultures were incubated for 3 days on a rotary shaker at 25°C and 50% relative humidity. The rotary shaker was operated at 220rpmwith a 5-cmthrow in a roomwith continuous fluorescent light. Twoml of this culture were then inoculated into fresh seed mediumto produce a second stage seed culture that was incubated similarly. Twoml of the resulting culture growth were used to inoculate either a solid corn-based or liquid production medium (Tables 1 and 2 ). The corn-based production medium A was incubated in 250-ml unbaffled Erlenmeyer flasks under static conditions at 25°C and 85% relative humidity for all the fermentation studies and initial isolation of australifungin. Fifty ml portions of the liquid production medium B were distributed into 250-ml unbaffled Erlenmeyer flasks. These flasks were incubated at 25°C on a; rotary shaker in a roomat 85%relative humidity for up to 21 days.
Media Components
The following nutrients were obtained from the sources indicated: yellow cracked corn, Bay-mor; Ardamine PH, Champlain Industries Inc.; oat flour, Quaker Oat Co. and Fidco yeast extract, Fidco division of Nestle Co., Inc. Carbon sources, amino acids, buffers and salts were reagent-or research-grade commercial products.
Isolation
Solid fermentations grown for 1 1 days were extracted by adding 50 ml of ethyl acetate to each flask. The material from 80 flasks was pooled, stirred with an overhead stirrer for 2 hours and filtered through a celite pad to yield an ethyl acetate extract (3, parts aqueous 25mMK2HPO4. It was then applied to the tail of a No. 14 analytical multilayer coil (P.C. Inc.) which had been filled completely with the lower phase of the above solvent system. The coil was then eluted with the upper phase of the solvent system at 3ml/minute from the tail to the head of the column, at a rotation speed of800 rpm in the forward direction collecting 7.5 ml fractions. Australifungin eluted after 435ml and the solvent was removed in vacuo to yield pure 1 (185mg). determined by microtiter broth dilution assay in Difco Yeast Nitrogen Base medium containing 2% glucose (YNBD) with fungi inoculated at OD600 = 7 x 10"4 (ca. 1 x 104 yeast cells or conidia/ml). Serial 2-fold dilutions of inhibitors were made from 32jug/ml (1) or 128 /ig/ml (2) TCAwas added and precipitates were harvested onto filtermats and radioactivity quantitated in a BetaPlate scintillation counter (Wallac). The same cultures were used to measure sphingolipid synthesis except duplicate samples of 0.4ml of cells were labeled with 0.5/xCi of 3H-sphinganine (10^m) for 30 minutes at 30°C. Lipids were extracted and the entire sample was subjected to mild alkaline methanolysis and TLC as described above.
The amount of incorporation of 3H-sphinganine into 3H-inositol phosphoceramide was quantitated using a BioScan counter.
In Vitro EnzymeAssays
Sphinganine 7V-acyltransferase activity was assayed using microsomal membranes from Candida albicans MY1055. To prepare membranefractions, the cells were grown to OD600 of 1. This strain can be assigned to the genus Sporormiella (Ascomycotina, Pleosporales) based on a combination of its saprobic coprophilous habitat, cleistothecioid or perithecioid pseudothecia, bitunicate asci, and transversely septate ascospores, with lateral germ slits surrounded by a gelatinous sheath. MF5672 can be identified as S.
australis because the asci are cylindrical with a short stipe, the ascospores are 4-celled, biseriately arranged in the ascus, and mostly between 35~40/mi long. The morphological characteristics of this strain agree well with descriptions published by Ahmedand Cain9) and by Ellis and Ellis10).
Fermentation
Antifungal activity was initially detected and isolated from extracts of S. australis grown on the solid corn-based medium A shown in Table 1 . Production of 1 in medium A started after day 7 and peaked at day 14 (67.1 jug/ml), and that of2 started after day 4 and peaked at day 18 (501/xg/ml) (Fig. 2) . Several liquid agitated media were screened, and liquid medium B ( Table 2) was found to produce a 4.6-to 5-fold increase in the titer of 1 at day 14 using either mannitol or fructose as the soluble carbon source.
Isolation and Physico-chemical Properties The isolation of 1 and 2 is summarized in Fig. 3 . Solid fermentations were extracted with ethyl acetate and liquid fermentations were acidified to pH3 before extraction with an equal volume of ethyl acetate. Compound1 and 2 were easily separable by column chromatography on silica gel and 2 readily purified by preparative reverse phase HPLC. Compound 1, however, required elevated temperatures to obtain satisfactory peak shape for reverse phase HPLC, making preparative HPLC impractical. This poor chromatographic behavior was probably due to extensive keto-enol tautomerism4) and the chelating Each point is a meantiter of three flasks analyzed by HPLC. Fig. 3 . Isolation scheme for australifungin (1) and australifunginol (2) from fermentations of Sporormiella australis. property of the /Mcetoaldehyde functionality. Final purification of 1 was accomplished using high speed countercurrent chromatography. A solvent system was developed by measuring the partition coefficient for lOOmg of 1 in a series of hexane-ethyl acetatemethanol-buffer systems. A solvent system (7 : 3 : 5 : 5) yielding a partition coefficient of 0.69 (organic/aqueous) was selected for chromatography. The physico-chemical properties of 1 and 2 are summarized in Table 3 and the structure is shown in Fig. 1 . *H and 13C NMRdata as well as details of the structure elucidation will be published elsewhere4).
Biological Activity
Antifungal Activity Antifungal activity against human pathogenic yeasts and filamentous fungi for 1 and 2 was evaluated in a. microbroth dilution assay as shown in Table 4 .
Australifungin had MICs of 1 /ig/ml or less against all of the species tested, with particularly good activity against Candida pseudotropicalis, C. tropicalis, and Cryptococcus neoformans. Much weaker activity was detected for australifunginol with MICs between 8 and 64 jug/ml. Both compounds were fungicidal in this assay (data not shown).
Sphingolipid Synthesis
Investigations into the mechanism of antifungal activity for 1 revealed changes in lipid biosynthesis, with specific inhibition of the inositol-containing sphingolipids. Fig. 4 shows that 1, at 0.25 jug/ml, almost completely inhibited 3H-inositol incorporation into the deacylation resistant sphingolipids in C. albicans, with relatively little effect on phosphatidylinositol synthesis. Whenthe cells were labeled with 3H-palmitate, a precursor to the sphingolipid pathway, 1 inhibited incorporation into the mature sphingolipids but not the deacylation sensitive phospholipids. A new 3H-palmitate-labeled lipid that comigrated with phytosphingosine accumulated with australifungin treatment (Fig. 4) . A similar pattern of Table 4 . Antifungal activity by microbroth dilution assay. inhibition of the mature sphingolipids and accumulation of phytosphingosine was also found in 3H-sphinganine and 3H-serine labeled lipids (not shown). At 25 /ig/ml, 2 had minimal effects on sphingolipid or phospholipid synthesis, although a small amount of phytosphingosine was visible in 3H-palmitate labeled cells (Fig. 4 ) and 3H-sphinganine labeled cells. Table 5 . Effects of australifungin (1) and australifunginol (2) In Vitro Enzyme Activity The accumulation of phytosphingosine with australifungin treatment suggested a block at ceramide synthesis; this was confirmed in an in vitro enzyme assay for sphinganine JV-acyltransferase.
The assay, which employs 3H-sphinganine and lignoceroyl-CoA as substrates with microsomal membranes prepared from C. albicans, results in the in vitro synthesis of two products, one of which comigrates with lignoceroyl sphinganine and releases 3H-sphinganine upon acid hydrolysis, and the other which releases 3H-phytosphingosine upon acid hydrolysis. Australifungin inhibited the synthesis of both products, as shown in Fig. 5 . The phytosphingosinecontaining ceramide was slightly more sensitive to 1 with an IC50 of 15ng/ml (37nM); the IC50 for the sphinganine-containing form was 38 ng/ml (93 nM). As expected from the whole cell labeling results, inhibition by 1 was specific for the sphinganine 7V-acyltransferase. The first enzyme in the sphingolipid pathway, the serine palmitoyltransferase, was not sensitive to 10 /ig/ml of 1. The less active analog, 2, also inhibited the sphinganine 7V-acyltransferase in vitro, but was at least 50-fold less potent. acyltransferase, the fumonisins3'1 5) and AALtoxins16). The fumonisins were initially isolated as tumor promoting agents found in contaminated corn feed15) and are associated with severe toxicological effects such as equine leucoencephalomalacia and porcine pulmonary edema17). These compounds are the subject of intense examination to ascertain their natural occurrence and determine whether toxicity is mechanism based. Ceramide is the precursor to sphingomyelin, gangliosides, and glycosphingolipids, and is also a central intermediate in the metabolic pathway that may function as a lipid signal transduction pathway18). Ceramide and its derivatives, have been implicated as second messengers in cell differentiation, cell death by apoptosis, and cell proliferation19).
Thus, disruption of ceramide synthesis by fumonisin, and the accumulation of the bioactive sphingoid bases has been suggested as the likely mechanism of toxicity and carcinogenicity20). Australifungin, which is structurally unrelated to sphingolipids and lacks a free amine group that in fumonisin, is critical for its toxic activity, should prove useful for dissecting the complex role of sphingolipids in cell regulation and evaluating the mechanism of fumonisin toxicity.
Australifungin is structurally related to several other phytotoxins.
The /?-ketoaldehyde functional group, which is relatively rare in a natural product, and the basic ring structure is shared by stemphyloxin (3)21) and betaenone C (4)22). Reduction of the /?-ketoaldehyde to the alcohol in betaenone B (5) reduces potency, as we have found for australifunginol (2) . The mechanism of phytotoxic activity of the betaenones has not been reported, while stemphyloxin has been proposed to interfere with iron metabolism as it is a chelating agent2 x\ Although lacking the /?-ketoaldehyde group, structural similarity to the mycotoxin, diplodiatoxin23), is also evident. Diplodiatoxin has been isolated from Fusarium moniliforme2*\ the producer of the fumonisins15), and like the fumonisins, is associated with severe toxicity in animals that consume contaminated corn. Inhibition of ceramide synthesis maybe a mechanismcommon to all of these toxins.
